Are Y90 -therspheres, reported with code 79445 , Radiopharmaceutical therapy, by intra-arterial particulate administration, used for transcatheter selective arterial embolization, considered a radioisotope agent? If the physician is performing 37243 , Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (eg, congenital or acquired venous malformations, venous and capillary hemangionas, varices, varioceles); for tumors, organ ischemia, or infarction, with the Y90 -theraspheres may both codes be reported? ...

Subscribe or sign in to view the full article.

Sign In Subscribe Today

Note:  The following article synopsis was NOT provided by the AMA. It was created by Find-A-Code/innoviHealth.

Article Overview

This article addresses CPT coding questions about intra-arterial radiopharmaceutical therapy using Y90 TheraSpheres and its relationship to transcatheter vascular embolization services. It is intended for coding professionals working with oncology, interventional radiology, and nuclear medicine, and it explains the general reporting framework described in CPT for therapy administration, imaging, and related procedural services.

Why This Topic Matters

Accurate reporting of these services affects how nuclear medicine therapy and interventional procedures are captured in the medical record and coded for reimbursement. The article helps readers understand the scope of the CPT guidance and whether related services may be separately considered.

Codes Discussed

• CPT: 79445
• CPT: 37243

Subscribe or sign in to view the full article.

Sign In Subscribe Today